Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19.
Aerosols
/ analysis
Air Microbiology
Betacoronavirus
/ physiology
COVID-19
Coronavirus Infections
/ prevention & control
Health Personnel
Humans
Infectious Disease Transmission, Patient-to-Professional
/ prevention & control
Pandemics
/ prevention & control
Pneumonia, Viral
/ prevention & control
Protective Devices
SARS-CoV-2
Aerosol
COVID-19
Droplet
Infection control
Mask
SARS-CoV-2
Transmission
Journal
Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411
Informations de publication
Date de publication:
06 07 2020
06 07 2020
Historique:
received:
18
05
2020
accepted:
23
06
2020
entrez:
8
7
2020
pubmed:
8
7
2020
medline:
16
7
2020
Statut:
epublish
Résumé
To determine the risk of SARS-CoV-2 transmission by aerosols, to provide evidence on the rational use of masks, and to discuss additional measures important for the protection of healthcare workers from COVID-19. Literature review and expert opinion. SARS-CoV-2, the pathogen causing COVID-19, is considered to be transmitted via droplets rather than aerosols, but droplets with strong directional airflow support may spread further than 2 m. High rates of COVID-19 infections in healthcare-workers (HCWs) have been reported from several countries. Respirators such as filtering face piece (FFP) 2 masks were designed to protect HCWs, while surgical masks were originally intended to protect patients (e.g., during surgery). Nevertheless, high quality standard surgical masks (type II/IIR according to European Norm EN 14683) appear to be as effective as FFP2 masks in preventing droplet-associated viral infections of HCWs as reported from influenza or SARS. So far, no head-to-head trials with these masks have been published for COVID-19. Neither mask type completely prevents transmission, which may be due to inappropriate handling and alternative transmission pathways. Therefore, compliance with a bundle of infection control measures including thorough hand hygiene is key. During high-risk procedures, both droplets and aerosols may be produced, reason why respirators are indicated for these interventions.
Identifiants
pubmed: 32631450
doi: 10.1186/s13756-020-00763-0
pii: 10.1186/s13756-020-00763-0
pmc: PMC7336106
doi:
Substances chimiques
Aerosols
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
100Subventions
Organisme : Bundesamt für Gesundheit
ID : NA
Pays : International
Investigateurs
Carlo Balmelli
(C)
Marie-Christine Eisenring
(MC)
Stephan Harbarth
(S)
Jonas Marschall
(J)
Didier Pittet
(D)
Hugo Sax
(H)
Matthias Schlegel
(M)
Alexander Schweiger
(A)
Laurence Senn
(L)
Nicolas Troillet
(N)
Andreas F Widmer
(AF)
Giorgio Zanetti
(G)
Références
PLoS One. 2012;7(1):e29744
pubmed: 22295066
Influenza Other Respir Viruses. 2011 May;5(3):170-9
pubmed: 21477136
JAMA. 2020 Mar 4;:
pubmed: 32129805
Lancet Infect Dis. 2020 Apr 27;:
pubmed: 32353347
JAMA. 2019 Sep 3;322(9):824-833
pubmed: 31479137
J Occup Environ Med. 2015 May;57(5):501-8
pubmed: 25816216
JAMA. 2020 Mar 26;:
pubmed: 32215590
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Infect Control Hosp Epidemiol. 2006 May;27(5):473-8
pubmed: 16671028
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Ann Intern Med. 2009 Oct 6;151(7):437-46
pubmed: 19652172
Am J Respir Crit Care Med. 2013 May 1;187(9):960-6
pubmed: 23413265
J Hosp Infect. 2020 Jun;105(2):119-127
pubmed: 32259546
CMAJ. 2016 May 17;188(8):567-574
pubmed: 26952529
Emerg Infect Dis. 2020 Jun;26(6):1059-1066
pubmed: 32187007
PLoS One. 2020 Jan 27;15(1):e0227699
pubmed: 31986165
Clin Infect Dis. 2017 Oct 15;65(8):1335-1341
pubmed: 29017249
Clin Infect Dis. 2013 Feb;56(4):617
pubmed: 23155148
N Engl J Med. 2003 Mar 27;348(13):1256-66
pubmed: 12660390
Clin Infect Dis. 2017 Nov 13;65(11):1934-1942
pubmed: 29140516
Lancet Infect Dis. 2007 Apr;7(4):257-65
pubmed: 17376383
Ann Intern Med. 2020 Jun 2;172(11):766-767
pubmed: 32176257
Influenza Other Respir Viruses. 2020 Jul;14(4):365-373
pubmed: 32246890
Nature. 2020 Jun;582(7813):557-560
pubmed: 32340022
BMC Infect Dis. 2019 Jan 31;19(1):101
pubmed: 30704406
Emerg Infect Dis. 2005 Jul;11(7):1003-8
pubmed: 16022771
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):477-481
pubmed: 32298247
Rev Infect Dis. 1980 May-Jun;2(3):384-92
pubmed: 6997967
Nat Med. 2020 May;26(5):676-680
pubmed: 32371934
PLoS Pathog. 2013 Mar;9(3):e1003205
pubmed: 23505369
J Hosp Infect. 2015 Apr;89(4):225-8
pubmed: 25578684
JAMA. 2020 Feb 24;:
pubmed: 32091533
BMC Med. 2015 Sep 03;13:210
pubmed: 26336062
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):606-610
pubmed: 32407303
JAMA. 2009 Nov 4;302(17):1865-71
pubmed: 19797474
BMC Pulm Med. 2019 Oct 30;19(1):190
pubmed: 31666061
PLoS One. 2013;8(2):e56278
pubmed: 23418548
Emerg Infect Dis. 2020 Jul;26(7):1628-1631
pubmed: 32240078
MMWR Morb Mortal Wkly Rep. 2020 Mar 06;69(9):245-246
pubmed: 32134909
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1081-1086
pubmed: 29348203
J Infect Dis. 2020 Apr 16;:
pubmed: 32301491
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
Lancet. 2020 May 2;395(10234):e77-e78
pubmed: 32333843
N Engl J Med. 2003 Dec 18;349(25):2416-22
pubmed: 14681507
Nat Commun. 2020 May 29;11(1):2800
pubmed: 32472043
PLoS One. 2012;7(4):e35797
pubmed: 22563403
J Virol Methods. 2018 Oct;260:98-106
pubmed: 30029810
Clin Infect Dis. 2016 Mar 15;62(6):755-60
pubmed: 26679623